| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.07 |